Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.

A panel of expression markers was validated and used to document that, when radical prostatectomy specimens are cultured in low (i.e., <260 micromol/L)-calcium (Ca2+)-serum-free, growth factor-defined (SFD) medium, what grows out are not prostatic cancer cells but basally derived normal transit-amplifying prostatic epithelial cells. The selective outgrowth of the normal transit-amplifying versus prostatic cancer cells is due to the differential effect of low-Ca2+ medium on the structure of Notch-1 and E-cadherin signaling molecules. In low-Ca2+ medium, Notch-1 receptor is conformationally in a constitutively active, cell autonomous form not requiring reciprocal cell-cell (i.e., ligand) interaction for signaling. Such signaling is required for survival of transit-amplifying cells as shown by the death of transit-amplifying cells induced by treatment with a series of chemically distinct gamma-secretase inhibitors to prevent Notch-1 signaling. Conversely, in low-Ca2+ medium, E-cadherin is conformationally inactive preventing cell-cell homotypic interaction, but low cell density nonaggregated transit-amplifying cells still survived because Notch-1 is able to signal cell autonomously. In contrast, when medium Ca2+ is raised to >400 micromol/L, Notch-1 conformationally is no longer constitutively active but requires cell-cell contact for reciprocal binding of Jagged-1 ligands and Notch-1 receptors between adjacent transit-amplifying cells to activate their survival signaling. Such cell-cell contact is enhanced by the elevated Ca2+ inducing an E-cadherin conformation allowing homotypic interaction between transit-amplifying cells. Such Ca(2+)-dependent, E-cadherin-mediated interaction, however, results in cell aggregation, stratification, and inhibition of proliferation of transit-amplifying cells via contact inhibition-induced up-regulation of p27/kip1 protein. In addition, transit-amplifying cells not contacting other cells undergo squamous differentiation into cornified (i.e., 1% SDS insoluble) envelopes and death in the elevated Ca2+ medium. Stratification and contact inhibition induced by elevated Ca2+ are dependent on E-cadherin-mediated homotypic interaction between transit-amplifying cells as shown by their prevention in the presence of a cell-impermanent, E-cadherin neutralizing antibody. In contrast to growth inhibition of normal transit-amplifying cells, supplementation of low-Ca(2+)-SFD medium with 10% FCS and raising the Ca2+ to >600 micromol/L stimulates the growth of all prostate cancer cell lines tested. Additional results document that, at physiologic levels of Ca2+ (i.e., >600 micromol/L), prostatic cancer cells are not contact inhibited by E-cadherin interactions and Notch-1 signaling is no longer required for survival but instead becomes one of multiple signaling pathways for proliferation of prostatic cancer cells. These characteristic changes are consistent with prostate cancer cells' ability to metastasize to bone, a site of high-Ca2+ levels.

[1]  J. Isaacs,et al.  Enhanced Redundancy in Akt and Mitogen-activated Protein Kinase-induced Survival of Malignant versus Normal Prostate Epithelial Cells , 2004, Cancer Research.

[2]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[3]  T. Kadesch,et al.  Consequences of Notch-mediated induction of Jagged1. , 2004, Experimental cell research.

[4]  D. French,et al.  Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis during Development and Re-growth Following Castration and Androgen Replacement* , 2004, Journal of Biological Chemistry.

[5]  C. Korch,et al.  Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.

[6]  D. Selkoe,et al.  The Notch Ligands, Jagged and Delta, Are Sequentially Processed by α-Secretase and Presenilin/γ-Secretase and Release Signaling Fragments* , 2003, Journal of Biological Chemistry.

[7]  A. D. De Marzo,et al.  Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? , 2003, The Journal of clinical endocrinology and metabolism.

[8]  M. Loda,et al.  Intermediate basal cells of the prostate: In vitro and in vivo characterization , 2003, The Prostate.

[9]  Y. S. Tang,et al.  Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement. , 2003, Journal of medicinal chemistry.

[10]  W. Gage,et al.  Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. , 2003, The American journal of pathology.

[11]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[12]  L. Sokoll,et al.  Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models , 2003, The Prostate.

[13]  R. Reiter,et al.  Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. , 2002, Molecular cancer research : MCR.

[14]  J. Trent,et al.  α-methylacyl-CoA racemase: A new molecular marker for prostate cancer , 2002 .

[15]  J. Rhim,et al.  A novel human cancer culture model for the study of prostate cancer , 2001, Oncogene.

[16]  H. Koeppen,et al.  Dynamics of notch expression during murine prostate development and tumorigenesis. , 2001, Cancer research.

[17]  Alvin Y. Liu,et al.  Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression , 2001, Cell and Tissue Research.

[18]  W. Isaacs,et al.  A novel human cell culture model for the study of familial prostate cancer. , 2001, Cancer research.

[19]  J. Isaacs,et al.  Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. , 2001, Cancer research.

[20]  R. Dahiya,et al.  Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system , 2001, Cell Death and Differentiation.

[21]  R Montironi,et al.  p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.

[22]  J. Schalken,et al.  Demonstration of Intermediate Cells during Human Prostate Epithelial Differentiation In Situ and In Vitro Using Triple-Staining Confocal Scanning Microscopy , 2000, Laboratory Investigation.

[23]  Graeme Irvine Stevenson,et al.  L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase Activity , 2000 .

[24]  J. Sklar,et al.  Calcium Depletion Dissociates and Activates Heterodimeric Notch Receptors , 2000, Molecular and Cellular Biology.

[25]  Raphael Kopan,et al.  A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. , 2000, Molecular cell.

[26]  O. Pertz,et al.  A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E‐cadherin homoassociation , 1999, The EMBO journal.

[27]  D. S. Coffey,et al.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. , 1998, The American journal of pathology.

[28]  Robert S. Kerbel,et al.  E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.

[29]  G. Struhl,et al.  Nuclear Access and Action of Notch In Vivo , 1998, Cell.

[30]  H. Bonkhoff,et al.  Relation between Bcl‐2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer , 1998, The Prostate.

[31]  W. Isaacs,et al.  E1A transformed normal human prostate epithelial cells contain a 16q deletion. , 1997, Cancer genetics and cytogenetics.

[32]  R. K. Bright,et al.  Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. , 1997, Cancer research.

[33]  D. Grignon,et al.  Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma , 1996, Journal of cellular physiology.

[34]  C. Disteche,et al.  Chromosomal abnormalities in HPV-16-immortalized oral epithelial cells. , 1996, Carcinogenesis.

[35]  R W Veltri,et al.  Implication of cell kinetic changes during the progression of human prostatic cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  A. Hagemeijer,et al.  Tissue culture loss of aneuploid cells from carcinomas of the prostate , 1993, Genes, chromosomes & cancer.

[37]  W. Isaacs,et al.  Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells , 1993 .

[38]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[39]  J. Schalken,et al.  Decreased expression of E-cadherin in the progression of rat prostatic cancer. , 1992, Cancer research.

[40]  P. Schellhammer,et al.  Cytogenetic evaluation of 20 cultured primary prostatic tumors. , 1991, Cancer genetics and cytogenetics.

[41]  T. Stamey,et al.  Serum-free growth of adult human prostatic epithelial cells , 1986, In Vitro Cellular & Developmental Biology.

[42]  T. Stamey,et al.  Serial propagation of adult human prostatic epithelial cells with cholera toxin , 1984, In Vitro.

[43]  J. Lechner,et al.  Growth control of prostatic carcinoma cells in serum-free media: interrelationship of hormone response, cell density, and nutrient media. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Gindler,et al.  Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. , 1972, American journal of clinical pathology.

[45]  G. Aumüller,et al.  Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines , 2004, Urological Research.

[46]  J. Isaacs,et al.  In vitro culturing and characteristics of transit amplifying epithelial cells from human prostate tissue , 2004, Journal of cellular biochemistry.

[47]  M. Rubin,et al.  Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. , 2001, Cancer research.

[48]  T. Stamey,et al.  In vitro studies of human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells. , 1989, Growth factors.

[49]  R. Roberts,et al.  Bradykinin receptors: characterization, distribution and mechanisms of signal transduction. , 1989, Progress in growth factor research.

[50]  T. Stamey,et al.  Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone , 1986, The Prostate.